Slit protein-mediated inhibition of CXCR4-induced chemotactic and chemoinvasive signaling pathways in breast cancer cells.
about
Structural insights into the Slit-Robo complexThe Slit/Robo system suppresses hepatocyte growth factor-dependent invasion and morphogenesis.The axonal repellent, Slit2, inhibits directional migration of circulating neutrophilsSLITs suppress tumor growth in vivo by silencing Sdf1/Cxcr4 within breast epitheliumNetrin-1 inhibits leukocyte migration in vitro and in vivo.The SLIT-ROBO pathway: a regulator of cell function with implications for the reproductive systemInhibition of medulloblastoma cell invasion by SlitDifferential expression of novel potential regulators in hematopoietic stem cells.Mesenchymal Stem/Stromal Cells in Stromal Evolution and Cancer ProgressionThe emerging role of Slit-Robo pathway in gastric and other gastro intestinal cancersSlit/Robo pathway: a promising therapeutic target for cancerDeubiquitinating enzyme USP33/VDU1 is required for Slit signaling in inhibiting breast cancer cell migration.Elevated Slit2 Activity Impairs VEGF-Induced Angiogenesis and Tumor Neovascularization in EphA2-Deficient EndotheliumPredicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen.Quantification of SLIT-ROBO transcripts in hepatocellular carcinoma reveals two groups of genes with coordinate expressionSlit2 inhibits glioma cell invasion in the brain by suppression of Cdc42 activity.Navigating breast cancer: axon guidance molecules as breast cancer tumor suppressors and oncogenes.A novel role for Slit2/Robo1 axis in modulating HIV-1 replication in T cellsGlucocorticoid regulation of SLIT/ROBO tumour suppressor genes in the ovarian surface epithelium and ovarian cancer cells.A systematic analysis on DNA methylation and the expression of both mRNA and microRNA in bladder cancerSlit2N/Robo1 inhibit HIV-gp120-induced migration and podosome formation in immature dendritic cells by sequestering LSP1 and WASp.Angiocrine factors modulate tumor proliferation and motility through EphA2 repression of Slit2 tumor suppressor function in endothelium.Promoter hypermethylation-mediated inactivation of multiple Slit-Robo pathway genes in cervical cancer progressionEngineered three-dimensional microfluidic device for interrogating cell-cell interactions in the tumor microenvironment.Genome-Wide Analyses Suggest Mechanisms Involving Early B-Cell Development in Canine IgA Deficiency.Human placental expression of SLIT/ROBO signaling cues: effects of preeclampsia and hypoxiaThe brain within the tumor: new roles for axon guidance molecules in cancers.Slit2N Inhibits Transmission of HIV-1 from Dendritic Cells to T-cells by Modulating Novel Cytoskeletal Elements.Slit-2/Robo-1 modulates the CXCL12/CXCR4-induced chemotaxis of T cells.N-terminal Slit2 inhibits HIV-1 replication by regulating the actin cytoskeleton.Slit-2 induces a tumor-suppressive effect by regulating beta-catenin in breast cancer cells.The malignant phenotype of breast cancer cells is reduced by COX-2 silencing.Slit2 inhibits growth and metastasis of fibrosarcoma and squamous cell carcinomaCharacterization of the interaction between Robo1 and heparin and other glycosaminoglycans.Site-specific metastasis formation: chemokines as regulators of tumor cell adhesion, motility and invasion.Slit2/Robo4 Signaling: Potential Role of a VEGF-Antagonist Pathway to Regulate Luteal PermeabilityThe axonal attractant Netrin-1 is an angiogenic factor.A roundabout way to cancer.Cancer-associated fibroblasts as another polarized cell type of the tumor microenvironment.Slit2-Robo signaling in inflammation and kidney injury.
P2860
Q24293266-15696574-128B-4890-BBB8-9F4DEE290A31Q24314397-97ABD7C8-2273-4053-A07E-5C5FA567E8A7Q24316445-BA8B7EF2-F063-4C8C-9DEB-416216431B47Q24318278-1B515370-58B2-4A2F-9E4F-F843179230A7Q24534764-AC797D33-249D-40AF-AC8C-82F3CE46D4A1Q24616664-785A0B53-2EBE-47E1-A18F-CD8C022512A8Q24680387-E3B51454-3763-4C01-9B29-A3EC30088BCFQ24811837-450E85B4-2272-462A-9690-6A2CA3B0E078Q26770002-E37FAEAB-0683-4B0D-B70F-93D2040005C3Q26775454-C18A86C5-F5F9-48B5-B085-FA2B6A0D012DQ27026113-238F63E5-B43F-41CE-9DD3-978A78CA707CQ28585418-A2178AED-21E7-4EAA-B9B5-55B2E82B5C7CQ30646148-0631C2DA-D925-4291-8FF2-BB7EEF972ABAQ33337206-D894A8C0-84BC-4710-A6CB-6FEE1052BAA4Q33396358-C3D23A04-7B75-42B7-9ECF-F2523861F22BQ33574529-EE8C5AEE-5F29-4879-BBF7-2BE8D88FEFA5Q33853031-BB78C202-4221-4927-9C96-41273BCD824AQ34009882-F3C31787-42FE-4A5A-B8BC-C728CD12FC3EQ34087872-41EE40D2-111E-48B2-80F6-9F206D445EA0Q34091387-DDAD386E-2EC1-4983-B34F-38C6E20EC7D7Q34465457-7A72C7AE-7025-49EB-BD94-C5F582CE9152Q34547793-81B93296-6A37-44E5-87C6-EB2554B15018Q34695790-2BE69367-A428-42DB-88BA-74F0B2E61D90Q35402234-6483B915-B104-47B2-9C60-2B7DDBE52109Q35725850-7044FF26-8B66-4075-9D50-9E3585206B68Q35918271-85568908-7A48-43E5-A7BB-1EF83EA65AC3Q36193422-BEC93D65-239F-4E44-8A0B-F230E9E36381Q36297877-A5D50EC8-73A6-4FEA-A07E-A2280467DE3BQ36526659-D0C8C0D5-AE61-4758-970B-7DA11298D8E2Q36581559-25E555A4-A42A-4406-9002-7D1F869A93EEQ36897655-448C5620-84DB-43F7-8CD3-419745C4027EQ36944170-356BBB2B-3A71-440A-953C-5CBF9D2152E4Q36982125-C48B832E-58B0-4A78-A391-F49ACC6C2B5CQ37410475-FAE390C1-4715-45E2-9368-6782ABBBB9E2Q37528883-25A275E8-5309-4370-BB7F-DA5D5323F632Q37616257-0D4CC031-E1E9-4F8A-99C2-E669A9654986Q37621662-C7B0010D-688F-4CBC-A725-1431BF1823A9Q38010295-E696F83A-5EBD-4E5D-8659-9410D45CE75AQ38204745-1E7BB811-4821-4272-882E-A51E35C61C13Q38207912-FEDD4C1A-9D2A-4642-90C5-E89D4B8099D2
P2860
Slit protein-mediated inhibition of CXCR4-induced chemotactic and chemoinvasive signaling pathways in breast cancer cells.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Slit protein-mediated inhibiti ...... thways in breast cancer cells.
@en
type
label
Slit protein-mediated inhibiti ...... thways in breast cancer cells.
@en
prefLabel
Slit protein-mediated inhibiti ...... thways in breast cancer cells.
@en
P2093
P2860
P356
P1476
Slit protein-mediated inhibiti ...... thways in breast cancer cells.
@en
P2093
Aaron Z Fernandis
Anil Prasad
Ramesh K Ganju
P2860
P304
P356
10.1074/JBC.M308083200
P407
P577
2003-11-26T00:00:00Z